NCT04119232

Brief Summary

STEPUP is a 12-week randomized clinical trial among 126 postpartum women with pregnancies complicated by hypertensive disorders. Participants will be randomized to a control arm and receive a Fitbit or an intervention arm. The intervention arm will receive a Fitbit and set a step count goal, receive daily feedback via text about whether they reached their goal, and will be placed in virtual teams with other participants where they can win points for their team if they meet their daily goals. The main study outcomes will be increase in mean step count and change in psychosocial survey measures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
128

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 7, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 8, 2019

Completed
2 days until next milestone

Study Start

First participant enrolled

October 10, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 18, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 5, 2020

Completed
Last Updated

December 14, 2020

Status Verified

December 1, 2020

Enrollment Period

8 months

First QC Date

October 7, 2019

Last Update Submit

December 11, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in mean daily steps

    Change in mean daily step count from the baseline period (weeks 1-2) to the intervention period (weeks 3-14)

    weeks 3 to 14 of the intervention

Secondary Outcomes (12)

  • Proportion of participant-days that step goals are achieved

    weeks 3 to 14 of the intervention

  • Mean daily steps during the 12-week intervention period adjusted for baseline step count

    12-week intervention period

  • Change in perceived social support scale

    weeks 3 to 14 of the intervention

  • Change in Edinburgh postnatal depression scale (EPDS)

    weeks 3 to 14 of the intervention

  • Change in Systolic blood pressure

    weeks 3 to 14 of the intervention

  • +7 more secondary outcomes

Study Arms (2)

Control

NO INTERVENTION

Individual participants will use a wearable device to monitor daily step counts, set a step goal, and receive automated daily feedback on step goal attainment.

Social incentives-based program

EXPERIMENTAL

Individual participants will use a wearable device to monitor daily step counts, set a step goal, and receive automated daily feedback on step goal attainment. Participants will be placed on a team of 3 randomly assigned participants and receive the social incentives intervention.

Behavioral: Social incentives-based program

Interventions

Individual participants will use a wearable device to monitor daily step counts, set a step goal, and receive automated daily feedback on step goal attainment. Participants will be placed on a team of 3 randomly assigned participants and receive the social incentives intervention.

Social incentives-based program

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Delivered a live baby at HUP or PAH within 4.0-12.6 weeks prior to study enrollment;
  • Diagnosis of chronic hypertension, gestational hypertension, or preeclampsia during most recent pregnancy;
  • Participating in Heart Safe Motherhood (HSM) program;
  • Ability to read and provide informed consent to participate in the study;
  • Has smartphone and email address

You may not qualify if:

  • Does not speak English
  • Answers yes to any of the following questions:
  • Are you currently participating in any other physical activity studies?
  • Do you have any medical conditions or other reasons why you could not participate in a 12-week physical activity program?
  • Participants will be excluded after completing the baseline period if their baseline step count is too high (greater than or equal to 10,000 steps per day).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

Hypertension, Pregnancy-InducedPre-Eclampsia

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesHypertensionVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: We will conduct a two-arm randomized, controlled trial comparing a control group that uses wearable devices to track physical activity to an intervention group that uses the same wearable devices and participates in a team-based model of social incentives that gamifies physical activity. Patients will be randomized to one of the two arms.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 7, 2019

First Posted

October 8, 2019

Study Start

October 10, 2019

Primary Completion

June 18, 2020

Study Completion

October 5, 2020

Last Updated

December 14, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations